Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Lamb Weston
LW
$7.51B
| $10.9M | ﹤0.01% |
135,146
+60,620
| +81% | +$4.86M |
|
927
Melco Resorts & Entertainment
MLCO
$2.19B
| $10.7M | ﹤0.01% |
643,151
+187,031
| +41% | +$3.39M |
|
928
Ferrari
RACE
$68.6B
| $10.7M | ﹤0.01% |
51,654
-8,099
| -14% | -$1.69M |
|
929
Lennar Class A
LEN
$21.1B
| $10.6M | ﹤0.01% |
110,462
+38,972
| +55% | +$3.76M |
|
930
New Oriental
EDU
$8.08B
| $10.5M | ﹤0.01% |
128,021
-332,599
| -72% | -$40.4M |
|
931
Halliburton
HAL
$26.1B
| $10.5M | ﹤0.01% |
453,081
-1,720,362
| -79% | -$38.2M |
|
932
XPO
XPO
$24B
| $10.5M | ﹤0.01% |
216,323
+130,298
| +151% | +$6.36M |
|
933
Healthpeak Properties
DOC
$15.7B
| $10.4M | ﹤0.01% |
313,069
-281,486
| -47% | -$9.45M |
|
934
Magna International
MGA
$18.8B
| $10.3M | ﹤0.01% |
110,924
+22,723
| +26% | +$2.17M |
|
|
BNY
935
Bank of New York Mellon
BNY
$106B
| $10.2M | ﹤0.01% |
199,027
+1,213
| +0.6% | +$60.7K |
|
|
PPD
936
DELISTED
PPD, Inc. Common Stock
PPD
| $9.98M | ﹤0.01% |
+216,509
| New | +$9.78M |
|
937
Skyworks Solutions
SWKS
$9.73B
| $9.93M | ﹤0.01% |
51,766
-88,896
| -63% | -$15.8M |
|
938
Oneok
OKE
$55.9B
| $9.92M | ﹤0.01% |
178,290
+77,094
| +76% | +$4.11M |
|
939
PPG Industries
PPG
$26.5B
| $9.89M | ﹤0.01% |
58,252
-49,708
| -46% | -$8.53M |
|
940
Cognex
CGNX
$10B
| $9.87M | ﹤0.01% |
117,440
-402,470
| -77% | -$32.6M |
|
941
Takeda Pharmaceutical
TAK
$56B
| $9.71M | ﹤0.01% |
576,634
-74,960
| -12% | -$1.28M |
|
942
OR Royalties Inc
OR
$5.52B
| $9.64M | ﹤0.01% |
703,359
+165,781
| +31% | +$2.22M |
|
943
Jefferies Financial Group
JEF
$13.2B
| $9.63M | ﹤0.01% |
294,423
+2,277
| +0.8% | +$69.5K |
|
944
Franklin Resources
BEN
$17.3B
| $9.62M | ﹤0.01% |
300,616
+250,611
| +501% | +$8.12M |
|
945
Teladoc Health
TDOC
$1.69B
| $9.47M | ﹤0.01% |
56,971
-87,603
| -61% | -$14.2M |
|
946
PACCAR
PCAR
$72.7B
| $9.37M | ﹤0.01% |
157,440
-41,460
| -21% | -$2.54M |
|
|
VMEO
947
DELISTED
Vimeo
VMEO
| $9.36M | ﹤0.01% |
+191,046
| New | +$8.78M |
|
948
Vipshop
VIPS
$7.13B
| $8.95M | ﹤0.01% |
445,673
+415,137
| +1,360% | +$10.4M |
|
949
Anika Therapeutics
ANIK
$202M
| $8.86M | ﹤0.01% |
+204,638
| New | +$8.72M |
|
950
Berkshire Hathaway Class A
BRK.A
$1.1T
| $8.78M | ﹤0.01% |
21
-1
| -5% | -$420K |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.